Fulgent Genetics Inc.

FLGT | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.54

-$0.15 (-0.69%)

At close: Sep 21, 2026, 4:00 PM ET

$21.54

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.69%

(1D)

Rating

Updated: Sep 4, 2026

26.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $611.75M

1D Range

21.02 21.62

52W Range

13.46 31.04

Valuation (TTM)

PE -7.64

PB 0.61

EV/EBITDA -4.88

Valuation (NTM)

Forward PE N/A

Forward PEG 0.20

Price Target $19

Cash Flow

FCF Yield -17.0%

SBC Adj. FCF Yield -23.1%

SBC Impact -36.1%

Margins

Gross Margin 35.6%

Operating Margin -35.8%

FCF Margin -32.0%

Growth (CAGR)

Revenue 3Y | 5Y 1.8% | -18.7%

Dil EPS 3Y | 5Y 40.1% | -1570.9%

FCF 3Y | 5Y -113.9% | -193.1%

Returns

ROA -7.8%

ROE -7.9%

ROIC -11.1%

Financial Health

Net Cash

$256.55M

Current Ratio 6.34

Interest Coverage -504.67

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals glo...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 1,315

IPO Date Sep 28, 2016

Website www.fulgentgenetics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 6, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$19

Downside

-11.79%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞